Insider · CIK 0001727478
Diane Hendricks
Files at MNPR (Monopar Therapeutics). First filing -, latest -.
Diane Hendricks files SEC Form 4 as 10% owner at MNPR (Monopar Therapeutics). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Diane Hendricks has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | MNPR Monopar Therapeutics | JOther Common Stockindirect: See footnote | -43,499 | $0.00 | $0 | 567,580 | Dec 17, 2025 |
Questions about Diane Hendricks
Answered from the filings on this page, as of the latest one.
Is Diane Hendricks buying or selling?
Diane Hendricks has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Diane Hendricks's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Diane Hendricks has 0.
Where does Diane Hendricks file Form 4?
Diane Hendricks has filed Form 4 at MNPR (Monopar Therapeutics). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.